申请人:Eli Lilly and Company
公开号:US05556981A1
公开(公告)日:1996-09-17
This invention provides novel heterocyclic derivatives, their pharmaceutical formulations, and their use for antagonizing angiotensin II receptors in mammals.
该发明提供了新颖的杂环衍生物,它们的药物配方以及它们用于拮抗哺乳动物中的血管紧张素II受体的用途。